SCHEMBL737612

SCHEMBL737612

N#Cc1cccc(-c2cccc3ccccc23)n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 7/20 0.46
CTSS P25774 1/20 0.43
PIM1 P11309 1/20 0.43
KDM4E B2RXH2 7/20 0.42
ALDH1A1 P00352 6/20 0.42
HPGD P15428 5/20 0.42
HSD17B10 Q99714 5/20 0.42
GAA P10253 3/20 0.42
ALOX12 P18054 3/20 0.42
CASP1 P29466 3/20 0.42
CASP7 P55210 3/20 0.42
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
GLA P06280 2/20 0.42
TSHR P16473 2/20 0.42
HCRTR1 O43613 1/20 0.42
POLB P06746 1/20 0.42
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
MCL1 Q07820 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14198210 0.80 ALDH1A1 (0.51) KDM4EALDH1A1HPGDHSD17B10MEN1
SCHEMBL6577413 0.79 SOS2 (0.50) ALOX15CTSSALDH1A1HPGDHSD17B10
SCHEMBL9220648 0.78 CTSS (0.55) ALOX15CTSSPIM1KDM4EHTT
SCHEMBL29988787 0.78 CTSS (0.55) ALOX15CTSSPIM1KDM4EHTT
SCHEMBL18422914 0.78 CTSS (0.38) CTSSPIM1KDM4EALDH1A1SOS2
SCHEMBL21928085 0.77 DUSP3 (0.37) ALOX15CTSSPIM1KDM4EALDH1A1
SCHEMBL1771966 0.76 CTSS (0.53) ALOX15CTSSPIM1KDM4EMEN1
SCHEMBL16516559 0.76 ALOX15 (0.50) ALOX15PIM1KDM4EALDH1A1HPGD
SCHEMBL2035275 0.75 SQOR (0.49) ALOX15KDM4EALDH1A1HPGDHSD17B10
SCHEMBL19231296 0.75 IKBKB (0.41) CTSSPIM1ALDH1A1GAASOS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138348-B2 Using coordination polymerization catalyst EXXONMOBIL CHEMICAL PATENTS INC. (US) 2012-03-20 US disclosed
US-8138348-B2 Using coordination polymerization catalyst EXXONMOBIL CHEMICAL PATENTS INC. (US) 2012-03-20 US disclosed
US-8138348-B2 Using coordination polymerization catalyst EXXONMOBIL CHEMICAL PATENTS INC. (US) 2012-03-20 US disclosed
US-20080182989-A1 Methods For Oligomerizing Olefins With Chromium Pyridine Mono-Oxazoline Catalysts EXXONMOBIL CHEMICAL PATENTS INC. 2008-07-31 US disclosed
US-20080182989-A1 Methods For Oligomerizing Olefins With Chromium Pyridine Mono-Oxazoline Catalysts EXXONMOBIL CHEMICAL PATENTS INC. 2008-07-31 US disclosed
US-20080182989-A1 Methods For Oligomerizing Olefins With Chromium Pyridine Mono-Oxazoline Catalysts EXXONMOBIL CHEMICAL PATENTS INC. 2008-07-31 US disclosed
WO-2008085655-A1 METHODS FOR OLIGOMERIZING OLEFINS WITH CHROMIUM PYRIDINE MONO-OXAZOLINE CATALYSTS EXXONMOBIL CHEMICAL PATENTS INC. (US) 2008-07-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080182989-A1 Methods For Oligomerizing Olefins With Chromium Pyridine Mono-Oxazoline Catalysts OXER1, OXGR1, OXA1L ALOX15 726/4885CTSS 4276/4885PIM1 2979/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.